Ticagrelor, a new platelet aggregation inhibitor, is the world’s first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist. It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome.
Density: 1.67Melting Point: 138-140°C
Boling Point: 777.6±70.0 °C(Predicted)
Solubility: DMSO 105 mg/mL Water <1 mg/mL Ethanol 53 mg/mL
Appearance: Solid
Color: White to Off-White
pKa: 13.26±0.70(Predicted)
Storage Condition: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
Stability: Hygroscopic
Refractive Index: 1.744
Use: A reversible antagonist of the platelet purinergic P2Y12 receptor
